A multicenter trial comparing the luteinizing hormone releasing hormone analog Zoladex, with Zoladex plus flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group

Eur Urol. 1990:18 Suppl 3:28-9. doi: 10.1159/000463976.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Multicenter Study

MeSH terms

  • Buserelin / adverse effects
  • Buserelin / analogs & derivatives*
  • Buserelin / therapeutic use
  • Flutamide / adverse effects
  • Flutamide / therapeutic use*
  • Goserelin
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*

Substances

  • Goserelin
  • Flutamide
  • Buserelin